Bio Medica Laboratories Ltd Listed
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in...
GREY MARKET PREMIUM
+₹2
▲ +1.44% vs issue price
Issue Price
₹139.00
Est. Listing Price
₹141.00
Lot Size
1000
Issue Details
Open Date
2026-05-21
Close Date
2026-05-25
Allotment
2026-05-26
Face Value
₹10.00
Total Issue Size
37,72,000 shares (agg. up to ₹52 Cr) Cr
Issue Type
Bookbuilding IPO
Exchange
BSE SME
Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid |
|---|---|---|---|
| QIB | 15.94x | 36000.00 | 574000.00 |
| NII (HNI) | 1.30x | 1755000.00 | 2286000.00 |
| Retail | 2.92x | 1792000.00 | 5228000.00 |
| Market Maker | 1x | 1,89,000 | 1,89,000 |
| Total | 2.26x | 3583000.00 | 8088000.00 |
Financials (₹ Cr)
| Period | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|
| 30 Nov 2025 | 28.63 | 8.66 | 13.45 | 17.12 |
| 31 Mar 2025 | 38.33 | 9.79 | 15.21 | 14.73 |
| 31 Mar 2024 | 15.34 | 2.50 | 5.63 | 4.94 |
Key Ratios
Return on Equity
54.41
Return on Capital Employed
23.22
Return on Net Worth
54.41
PAT / Revenue
30.35
EBITDA / Revenue
47.11
Debt to Equity
2.23
EPS Pre-Issue
10.67
EPS Post-Issue
10.33
P/E Pre-Issue
13.03
P/E Post-Issue
13.45
Objects of the Issue
- Repayment of loan — ₹6.50 Cr
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises — ₹28.50 Cr
- General Corporate Purposes
Registrar & Allotment
Registrar
Skyline Financial Services Pvt.Ltd
Lead Managers
Narnolia Financial Services Ltd
Compare GMP Across IPOs
See how this IPO's GMP stacks up against every other live IPO.
Open GMP Charts →